🔎 Trials Near Me

Home › Myelofibrosis › Arizona

Pag-aaral pangklinika para sa Myelofibrosis sa Arizona

7 pag-aaral para sa Myelofibrosis ang naghahanap ng mga kalahok sa mga site sa Arizona.

Mga Lungsod sa Arizona

Opisyal na teksto ng pag-aaral (English)

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

  • The University of Arizona Cancer Center, Tucson
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 2, 2026 · NCT04176198

A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib

  • Banner MD Anderson Cancer Center, Gilbert
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 1, 2026 · NCT07623161

Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia

  • Banner MD Anderson, Gilbert
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Set 23, 2026 · NCT05320198

A Study to Evaluate INCA035784 in Participants With Myeloproliferative Neoplasms

  • Mayo Clinic Hospital, Phoenix
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Ago 6, 2026 · NCT07008118

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Scottsdale
Nagre-recruitObservasyonal na pag-aaral
Lahat ng edad · Lahat ng kasarian · Na-update Okt 28, 2025 · NCT03452774

Q702 for the Treatment of Patients With Hematologic Malignancies

  • Mayo Clinic in Arizona, Scottsdale
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 10, 2025 · NCT06712810

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

  • Banner MD Anderson Cancer Center, Gilbert
  • Mayo Clinic - Phoenix, Phoenix
Nagre-recruitPhase 3
Edad 18 pataas · Lahat ng kasarian · Na-update Set 25, 2025 · NCT06479135

Mula sa ClinicalTrials.gov, na-kuha noong Okt 5, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.